Chapter 6 reading Exhaustive Medical Study Guide: The Hematologic and Blood System

Overview and Primary Functions of the Blood System

  • The blood system, also known as the hematologic system, consists of the blood and the bone marrow.
  • Etymology of hematologic: hemat/o means blood, log means study of, and -ic means pertaining to.
  • Blood is the fluid tissue in the body, composed of 55%55\% liquid plasma and 45%45\% formed elements (blood cells and platelets suspended in plasma).
  • Key physiological functions of the blood system:
    • Delivers oxygen (O2O_2) and nutrients directly to body cells and tissues.
    • Transports carbon dioxide (CO2CO_2), blood cells, immune cells, antibodies, and hormones throughout the body.
    • Removes metabolic waste products from tissues and delivers them to the liver and kidneys for excretion.
    • Returns carbon dioxide (CO2CO_2) to the lungs for elimination from the body.
    • Plays a vital role in fighting inflammation and supporting immune responses.
    • Regulates body skin temperature, pH balance, and fluid/water balance.

Medical Word Parts of the Blood System

  • chromat/o: Color
  • coagul/o: Clotting, coagulation
  • -emia: Blood, blood condition
  • erythr/o: Red
  • fibrin/o: Fibrin, fibers, threads of a clot
  • -globin: Protein
  • hem/o, hemat/o: Blood, relating to the blood
  • leuk/o: White
  • myel/o: Spinal cord, bone marrow
  • -oid: Resembling
  • -penia: Deficiency
  • phleb/o: Vein
  • plasm/o: Plasma, something molded or formed
  • -poiesis: To make
  • -stasis: Maintenance of a constant level

Primary Vocabulary and Medical Terms Glossary

  • Allogeneic transfusion (pronounced al-low-jen-e-a-tic): A blood transfusion using compatible donor blood.
  • Anticoagulant (pronounced an-ti-co-ag-u-lant): A substance or medication that slows coagulation and prevents new clots from forming.
  • Antigen (pronounced an-ti-gen): Any substance that the body regards as foreign, triggering an immune response.
  • Aplastic anemia (pronounced a-plas-tic a-ne-mi-a): Severe condition characterized by an absence of all formed blood elements due to bone marrow failure.
  • Autologous transfusion (pronounced au-to-al-lo-gus): A transfusion using the patient's own stored blood.
  • Basophils (pronounced ba-so-phils): Granulocytic white blood cells responsible for releasing histamine during allergic reactions.
  • Coagulation (pronounced co-ag-u-la-tion): The process of blood clotting.
  • Coagulopathy (pronounced co-ag-u-lop-a-thy): Any disease or condition affecting the blood's ability to coagulate.
  • Decompression sickness: A potentially fatal condition caused by nitrogen gas bubbles forming in the blood during rapid ascent from high-pressure environments.
  • Direct antiglobulin test (DAT): A test used to detect immune-mediated destruction of red blood cells.
  • Eosinophils (pronounced e-o-sin-o-phils): Granulocytic white blood cells that destroy parasites and participate in allergic reactions.
  • Erythrocyte (pronounced e-ryth-ro-cyte): Mature red blood cell responsible for oxygen transport.
  • Erythropoietin (pronounced e-ryth-ro-poi-e-tin): A hormone produced by the kidneys that stimulates red blood cell production in the bone marrow.
  • Fibrin (pronounced fye-brin): A web-like protein formed during blood clotting.
  • Fibrinogen (pronounced fi-brin-o-gen): A plasma precursor protein converted to fibrin during blood coagulation.
  • Globulins (pronounced glob-u-lins): A group of plasma proteins essential for immune system function.
  • Granulocytes (pronounced gran-u-lo-cytes): Leukocytes containing protein granules (neutrophils, eosinophils, basophils).
  • Hematologist (pronounced he-ma-tol-o-gist): A physician specializing in diagnosing and treating blood disorders.
  • Hematopoiesis (pronounced he-ma-to-poi-e-sis): The process of blood cell formation.
  • Hematopoietic stem cells: Unspecialized stem cells capable of differentiating into all blood cell types.
  • Hematocrit (pronounced he-mat-o-crit): The percentage of blood volume composed of erythrocytes.
  • Hemoglobin (pronounced he-mo-glo-bin): The iron-containing protein pigment in erythrocytes that carries oxygen.
  • Hemolysis (pronounced he-mol-y-sis): The breakdown and destruction of red blood cells.
  • Hemolytic anemia (pronounced he-mo-lit-ic a-ne-mi-a): Anemia resulting from premature destruction of erythrocytes.
  • Hemophilia (pronounced he-mo-phil-i-a): A hereditary bleeding disorder characterized by deficiency of specific clotting factors.
  • Hemostasis (pronounced he-mo-sta-sis): The stoppage or control of bleeding.
  • Hemorrhage (pronounced hem-or-rhage): Rapid, excessive loss of blood in a short duration.
  • Heparin (pronounced hep-a-rin): A fast-acting anticoagulant medication.
  • Hereditary spherocytosis (pronounced spher-o-cy-to-sis): A genetic disorder resulting in spherical, fragile erythrocytes.
  • Immunoglobulins (pronounced im-mu-no-glob-u-lins): Specialized plasma proteins (antibodies) produced by plasma cells.
  • Leukemia (pronounced leu-ke-mi-a): Progressive blood cancer characterized by an overproduction of abnormal leukocytes.
  • Leukocytes (pronounced leu-ko-cytes): White blood cells that defend the body against infections.
  • Leukopenia (pronounced leu-ko-pe-ni-a): An abnormally low count of circulating white blood cells.
  • Lipoprotein panel: A blood test measuring blood lipid levels (cholesterol and triglycerides).
  • Lymphocytes (pronounced lim-pho-cytes): Specialized leukocytes (T cells and B cells) providing specific immune responses.
  • Megakaryocytes (pronounced meg-a-kar-y-o-cytes): Giant bone marrow cells that fragment to form platelets.
  • Monocytes (pronounced mon-o-cytes): The largest leukocytes, providing immune defense via phagocytosis.
  • Multiple myeloma (pronounced my-e-lo-ma): Cancer of the plasma cells in the bone marrow.
  • Neutropenia (pronounced neu-tro-pe-ni-a): An abnormally low number of neutrophils in the blood.
  • Neutrophils (pronounced neu-tro-phils): The most common white blood cells; active phagocytes.
  • Non-Hodgkin's lymphoma: A broad category of lymphomas lacking Reed-Sternberg cells.
  • Pancytopenia (pronounced pan-cy-to-pe-ni-a): A severe reduction in erythrocytes, leukocytes, and platelets.
  • Pernicious anemia (pronounced per-ni-cious a-ne-mi-a): Anemia caused by intrinsic factor deficiency preventing vitamin B12B_{12} absorption.
  • Phagocytes (pronounced phag-o-cytes): Immune cells that engulf and digest pathogens and cellular debris.
  • Phlebotomist (pronounced fle-bot-o-mist): A medical specialist trained to perform venipuncture.
  • Plasma (pronounced plas-ma): The liquid constituent of unclotted blood.
  • Plasmapheresis (pronounced plas-ma-phe-re-sis): Procedure separating blood cells from plasma.
  • Platelets: Cell fragments involved in hemostasis and clot formation.
  • Prothrombin time (pronounced pro-throm-bin): A diagnostic test measuring blood clotting time.
  • Reticulocytes (pronounced re-tic-u-lo-cytes): Immature red blood cells recently released from bone marrow.
  • Rh factor: An antigen present on the erythrocytes of Rh+Rh+ individuals.
  • Sepsis (pronounced sep-sis): A severe, life-threatening systemic response to infection in the bloodstream.
  • Serum: Clear plasma fluid remaining after blood cells and clotting proteins are removed.
  • Sickle cell anemia: A hereditary blood disorder causing malformed, sickle-shaped erythrocytes.
  • Thalassemia (pronounced thal-a-sse-mi-a): An inherited blood disorder causing impaired hemoglobin synthesis.
  • Therapeutic plasma exchange (TPE): A specialized plasmapheresis removing disease-causing antibodies.
  • Thrombocytes (pronounced throm-bo-cytes): Technical term for blood platelets.
  • Thrombocytopenia (pronounced throm-bo-cy-to-pe-ni-a): Abnormally low platelet count.
  • Transfusion reaction: A severe immune response caused by incompatible blood transfusion.
  • Von Willebrand disease (pronounced von Wil-le-brand): A common inherited bleeding disorder caused by missing or defective von Willebrand factor.

Learning Objectives

  • Explain the physiological functions of the hematologic system.
  • Identify the major fluid and cellular components of blood along with their primary functions.
  • Differentiate between the four major blood types (AA, BB, ABAB, OO).
  • Identify medical specialists who diagnose and treat blood system disorders.
  • Identify key medical word parts related to the blood system.
  • Define primary terms related to the pathology and treatment procedures of hematologic diseases.
  • Describe diagnostic test procedures used to assess the blood system.
  • Spell primary medical terms of the blood system correctly.
  • Pronounce primary terms of the blood system correctly.
  • Identify common abbreviations related to the hematologic system.

Detailed Fluid and Cellular Components of Blood

  • Composition of whole blood:
    • Separated via centrifugation into top plasma layer (55%55\% volume) and bottom formed elements layer (45%45\% volume).
  • Plasma Details:
    • Straw-colored liquid constituent containing nutrients, hormones, and metabolic wastes.
    • Consists of 92%92\% water.
    • Remaining 8%8\% consists of essential blood proteins produced in the liver:
    • Albumin: Main protein in blood; maintains colloid osmotic pressure to prevent fluid leaking out of vessels into surrounding tissue.
    • Globulins: Protein group performing essential immune functions.
    • Fibrinogen and Prothrombin: Clotting proteins required for blood coagulation.
    • Serum: The clear, pale yellow fluid remaining after blood cells and clotting proteins (fibrinogen, prothrombin) are fully removed from plasma.
  • Formed Elements Details:
    • Categorized as formed elements because they possess a distinct structure and shape.
    • Erythrocytes (Red Blood Cells):
    • Comprise approximately 45%45\% of whole blood volume.
    • Disc-shaped cells that carry oxygen from lungs to body tissues.
    • Contain hemoglobin (Hgb), a blood protein pigment (hem/o = blood, globin = protein) containing the red compound heme.
    • Production is stimulated by erythropoietin (EPO), a hormone released by the kidneys.
    • Leukocytes (White Blood Cells / WBCs):
    • Defend against pathogens and foreign substances (leuk/o = white, -cyte = cell).
    • Granulocytes (contain protein granules inside cytoplasm):
      • Neutrophils: Formed in red bone marrow; most common WBC type. Act as phagocytes (phag/o = to eat/swallow, -cyte = cell) alongside macrophages to engulf bacteria, viruses, and fungi.
      • Basophils: Formed in red bone marrow; least common WBC type. Responsible for histamine release during allergic reactions.
      • Eosinophils: Formed in red bone marrow, then migrate to body tissues. Destroy parasites and mediate allergic responses.
    • Agranulocytes / Other Leukocytes:
      • Lymphocytes: Formed in red bone marrow, lymph nodes, and spleen. Include T cells and B cells. Identify antigens and produce targeted antibodies. B cells mature into plasma cells in bone marrow to secrete immunoglobulins.
      • Monocytes: Formed in red bone marrow, lymph nodes, and spleen; largest WBC type. Provide immunological defense via phagocytosis.
    • Platelets (Thrombocytes):
    • Smallest formed elements; small, colorless, amorphous cell fragments (thromb/o = clot, -cyte = cell).
    • Produced by large precursor cells in bone marrow called megakaryocytes.
    • When blood vessels are injured, platelets become sticky and clump together to form a platelet plug/clot.

Hematopoiesis and Cell Maturation

  • Definition: Hematopoiesis (hem/o = blood, -poiesis = to make) is the physiological process of blood cell formation.
  • Process of Differentiation:
    • Hematopoietic stem cells (HSCs) / hemocytoblasts undergo differentiation, taking on specific mature forms and functions.
    • Lineage Flowchart:
    • HSCs divide into Lymphoid Progenitor Cells and Myeloid Progenitor Cells.
    • Lymphoid Progenitor Cells differentiate into T cells and B cells.
    • Myeloid Progenitor Cells differentiate into Neutrophils, Basophils, Eosinophils, Monocytes, Erythrocytes, and Platelets.
  • Sites and Rates of Production:
    • Prenatal: Takes place in the spleen, liver, and bone marrow of the developing embryo.
    • Lifetime: Takes place continuously within the red bone marrow at the core of most bones.
    • Daily output: Over 100,000,000,000100{,}000{,}000{,}000 (101110^{11}) new blood cells are produced daily.
  • Circulating Cells and Maturation:
    • Peripheral blood: The blood circulating throughout the systemic blood vessels.
    • Reticulocytes: Newly released red blood cells from bone marrow that mature in circulating blood within approximately 1 day1\,day. Reticulocyte counts evaluate bone marrow, kidney, and liver function, or recent major blood loss.
    • Lymphocyte maturation: B cells mature inside the bone marrow. T cells migrate from bone marrow to the thymus (referred to as thymocytes) to mature, enabling cell-mediated immunity.

Blood Types, Genetics, and the Rh Factor

  • Antigens: Substances recognized by the immune system as foreign, capable of triggering immune responses.
  • The ABO Blood Group System:
    • Type A: Erythrocytes display A antigens (spherical structure); plasma contains Anti-B antibodies (pink Y-shape). Can receive blood from Types A and O; can donate to Types A and AB.
    • Type B: Erythrocytes display B antigens (diamond structure); plasma contains Anti-A antibodies (green Y-shape). Can receive blood from Types B and O; can donate to Types B and AB.
    • Type AB: Erythrocytes display both A and B antigens; plasma contains no anti-A or anti-B antibodies. Universal Recipient (can receive blood from Types A, B, AB, and O); can donate only to Type AB.
    • Type O: Erythrocytes display no ABO antigens (O represents zero); plasma contains both Anti-A and Anti-B antibodies. Universal Red Blood Cell Donor (can donate to Types A, B, AB, and O); can receive blood only from Type O.
  • Genetics of Blood Types:
    • Biological parents donate one ABO gene to their child (six possible genetic combinations).
    • Dominance: A and B genes are dominant; O gene is recessive.
    • Inheritance combinations:
    • Parent 1: A, Parent 2: A β†’\rightarrow Child: A
    • Parent 1: A, Parent 2: O β†’\rightarrow Child: A
    • Parent 1: A, Parent 2: B β†’\rightarrow Child: AB
    • Parent 1: B, Parent 2: B β†’\rightarrow Child: B
    • Parent 1: B, Parent 2: O β†’\rightarrow Child: B
    • Parent 1: O, Parent 2: O β†’\rightarrow Child: O
    • Parent 1: AB, Parent 2: AB β†’\rightarrow Child: A, B, or AB
  • The Rh Factor System:
    • Named after rhesus monkeys where the Rh antigen was first discovered.
    • Approximately 85%85\% of Americans are Rh-positive (Rh+Rh+), possessing the Rh antigen.
    • Approximately 15%15\% of Americans are Rh-negative (Rhβˆ’Rh-), lacking the Rh antigen.
    • Inheritance: Rh-positive gene is dominant over Rh-negative.
    • Clinical Risk: If an Rhβˆ’Rh- mother carries an Rh+Rh+ fetus, maternal sensitization can occur. Rho(D) immunoglobulin (RhoGAM) is administered during pregnancy to prevent the mother from producing anti-Rh antibodies.
  • Transfusion Matching Guidelines:
    • Type Oβˆ’O- is the universal donor blood for red blood cell transfusions because it lacks A, B, and Rh antigens.
    • Rh+Rh+ individuals can receive Rh+Rh+ or Rhβˆ’Rh- blood; Rhβˆ’Rh- individuals must receive Rhβˆ’Rh- blood.
    • Population distribution: In the United States, O+O+ and A+A+ together represent about 70%70\% of the population. ABβˆ’AB- is very rare.
    • Rare blood types exist when specific antigens among over 600600 other known minor blood antigens are present or missing.

Blood Gases, Hemostasis, and Coagulation

  • Blood Gases:
    • Dissolved gases present in blood fluid: Oxygen (O2O_2), Carbon Dioxide (CO2CO_2), and Nitrogen (N2N_2).
    • Erythrocytes transport O2O_2 from lungs to body tissues and return CO2CO_2 to lungs for exhalation.
    • Inhaled gaseous N2N_2 cannot be absorbed directly by human tissues; dietary food and water supply required nitrogen.
  • Hemostasis Mechanisms:
    • Hemostasis (hem/o = blood, -stasis = stopping/controlling): Physiological process stopping or controlling bleeding.
    • Physiological steps: Blood vessel vasoconstriction followed by platelet aggregation and protein clotting cascade.
    • Mechanical Hemostasis: External interventions (e.g., applying a tourniquet) used in trauma or surgery.
  • Blood Coagulation:
    • Coagulation (coagul = clotting, -ation = action): The process of blood clot formation.
    • Plasma proteins involved: Thrombin and Fibrinogen.
    • Fibrinogen is activated at injury sites into web-like threads called fibrin, forming a mesh that traps blood cells to form a scab.
    • Increased fibrin formation with age elevates the clinical risk of dangerous internal blood clots.

Medical Specialties

  • Hematologist: A specialized physician diagnosing and treating abnormalities, diseases, and disorders of blood and blood-forming tissues (hemat = blood, -ologist = specialist).
  • Phlebotomist: A medical professional trained to perform venipuncture to draw blood for diagnostic testing (phleb/o = vein).

Hematologic Pathology: Clotting and Bone Marrow Disorders

  • Blood Clotting Disorders:
    • Hypercoagulable State: Increased tendency of blood to form clots. Most common genetic cause is Factor V Leiden; acquired causes include trauma, surgery, and medications. Elevates risk for deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, myocardial infarction, or limb loss.
    • Coagulopathy: Any condition where blood coagulation is pathologically impaired.
    • Hemophilia: Inherited bleeding disorder characterized by deficiency of specific clotting factors, causing abnormal bleeding and spontaneous hemorrhages. Predominantly affects males.
    • Von Willebrand Disease (VWD): Most common genetic bleeding disorder; impacts women more than men. Results from low levels or dysfunction of von Willebrand factor, leading to severe bleeding and menorrhagia.
  • Bone Marrow Malignancies (Blood Cancers):
    • Leukemia: Cancer marked by progressive increase in abnormal leukocytes (leuk = white, -emia = blood condition) that crowd out functional blood cells in bone marrow.
    • Acute Myeloid Leukemia (AML): Most common leukemia in young children. Myeloid (myel = bone marrow, -oid = resembling) refers to abnormal myeloblast proliferation.
    • Chronic Lymphocytic Leukemia (CLL): Most common adult leukemia, involving abnormal, non-functional lymphocytes.
    • Lymphoma: Malignancy affecting lymphoid tissues (lymph = lymph, -oma = tumor) including lymph nodes, spleen, liver, and bone marrow.
    • Hodgkin's Lymphoma (HL): Distinguished by the presence of giant cancerous cells called Reed-Sternberg cells. Highly treatable in early stages.
    • Non-Hodgkin's Lymphoma (NHL): All other lymphomas originating in lymphocytes. Can be indolent (slow-growing) or aggressive (fast-growing). Majority of cases occur in individuals over age 65$.\n - Multiple Myeloma: Second most common blood cancer. Mutated plasma cells proliferate in bone marrow, crowding out healthy blood cells and creating destructive bone lesions ("soft spots").\n- Other Bone Marrow Conditions:\n - Aplastic Anemia: Severe condition caused by failure of bone marrow stem cells, resulting in complete absence of all formed blood elements (`a-` = without, `plast` = growth, `-ic` = pertaining to).\n - Myelodysplastic Syndrome (MDS): Cancer marked by insufficient production of functional blood cells due to bone marrow dysfunction (`myel/o` = bone marrow, `dys-` = bad, `plastic` = pertaining to formation). May progress to AML.\n - Pancytopenia: Abnormally low counts of erythrocytes, leukocytes, and platelets simultaneously.\n\n# Hematologic Pathology: Gas, Red Cell, and Infectious Disorders\n\n- Blood Gas Disorders:\n - Decompression Sickness (DCS / "The Bends"): Occurs during rapid ascent from deep-sea diving or unpressurized aviation. Nitrogen gas forms bubbles in blood and tissues, causing severe tissue damage or vessel obstruction. Treated with 100\% oxygen in a hyperbaric oxygen chamber.\n - Carbon Monoxide Poisoning: Inhalation of combustion fumes causes carbon monoxide to displace oxygen on hemoglobin, leading to severe hypoxia, tissue damage, and death.\n- General Blood Disorders:\n - Hemochromatosis (Iron Overload Disease): Genetic disorder causing excessive intestinal iron absorption (`hem/o` = blood, `chromat` = color, `-osis` = abnormal condition). Excess iron deposits in and damages internal organs.\n - Hereditary Spherocytosis: Genetic disease causing erythrocytes to adopt a spherical, fragile shape. Shortened cell lifespan causes splenic enlargement (splenomegaly) and anemia.\n - Leukopenia: Abnormally low count of circulating leukocytes (`leuk/o` = white, `-penia` = deficiency), impairing infection defense.\n - Neutropenia: Abnormally low neutrophil count, frequently caused by cancer chemotherapy, elevating vulnerability to life-threatening sepsis.\n - Polycythemia: Bone marrow overproduces erythrocytes (`poly-` = many, `cyt` = cell, `hem` = blood, `-ia` = condition), causing blood hyperviscosity and clot risks. Primary cause is polycythemia vera.\n - Thrombocytopenia: Abnormally low platelet count (`thromb/o` = clot, `cyt/o` = cell, `-penia` = deficiency), predisposing to bleeding.\n - Thrombocytosis: Abnormally high circulating platelet count, often secondary to tissue injury.\n - Hemorrhage: Rapid loss of a large volume of blood (`hem/o` = blood, `-rrhage` = bleeding), which can trigger fatal hemorrhagic shock.\n - Transfusion Reaction: Severe immune system complication caused by transfusing incompatible blood.\n- Anemias:\n - Anemia Definition: Decreased erythrocyte count or hemoglobin concentration (`an-` = without, `-emia` = blood condition), causing tissue hypoxia, fatigue, weakness, and dyspnea.\n - Iron Deficiency Anemia: Most common form; caused by lack of iron needed to synthesize hemoglobin (due to chronic blood loss, poor absorption, or inadequate intake). Pregnancy-related anemia results from high fetal iron demand.\n - Megaloblastic Anemia: Characterized by unusually large, immature erythrocytes (`megalo-` = large, `blast` = immature, `-ic` = pertaining to). Results from Vitamin B_{12} or folic acid deficiency.\n - Pernicious Anemia: Autoimmune lack of Intrinsic Factor (IF), preventing GI absorption of Vitamin B_{12} necessary for erythrocyte production.\n - Hemolytic Anemia: Premature destruction of erythrocytes (hemolysis) by the spleen (`hem/o` = blood, `lytic` = destroy).\n - Sickle Cell Anemia (SCA): Genetic disorder causing abnormal hemoglobin, producing rigid sickle-shaped red blood cells that clog vessels. Affects 1\,in\,365AfricanAmericansandAfrican Americans and1\,in\,1000\,to\,1500 Hispanic Americans in the US.\n - Thalassemia: Inherited DNA mutations impairing hemoglobin chain synthesis, leading to massive erythrocyte destruction.\n- Infectious Blood Diseases:\n - Malaria: Mosquito-transmitted parasite multiplies inside red blood cells, causing them to rupture. Prevented with prophylactic medications.\n - Sepsis and Septicemia: Sepsis is a systemic inflammatory response to infection in the bloodstream. Septicemia refers specifically to active bacterial proliferation in blood. Derived from Greek for decomposition/decay.\n\n# Diagnostic Procedures\n\n- Venipuncture: Puncturing a vein to collect blood samples, often centrifuged to separate blood cells from plasma or serum.\n- Complete Blood Count (CBC): Comprehensive evaluation measuring RBCs, WBCs, Hemoglobin, Platelets, Mean Corpuscular Volume (MCV), and Hematocrit.\n- Comprehensive Metabolic Panel (CMP / Chem 14): Measures 14 blood substances to evaluate overall metabolism, liver/kidney function, glucose, calcium, electrolytes, and proteins.\n- Basic Metabolic Panel (BMP / Profile 8): Measures 7\,to\,8 substances assessing kidney function and electrolytes (sodium, potassium, chloride, bicarbonate, BUN, creatinine, glucose, optional calcium).\n- Blood Urea Nitrogen (BUN) Test: Measures blood urea nitrogen levels to evaluate liver and kidney health.\n- Direct Antiglobulin Test (DAT / Direct Coombs Test): Detects antibodies attached to RBCs to diagnose hemolytic transfusion reactions or hemolytic disease of the newborn.\n- Coagulation Panel: Tests blood clotting factor performance and monitors anticoagulant therapies.\n- Blood Differential Test: Measures the relative percentage of each white blood cell type.\n- Blood Enzyme Tests: Measures circulating enzymes (e.g., cardiac troponin following heart muscle injury).\n- Arterial Blood Gas (ABG) Test: Measures arterial O_2,,CO_2, and pH levels to evaluate lung and kidney function.\n- Blood Glucose Test: Measures circulating blood glucose levels to evaluate insulin function and manage diabetes.\n- Erythrocyte Sedimentation Rate (ESR / Sed Rate): Measures the rate at which red blood cells settle to the bottom of a tube; elevated rates signal systemic inflammation.\n- Fibrinogen Activity Test: Measures fibrinogen availability to investigate unexplained bleeding.\n- Glucose Tolerance Test: Oral screening test for gestational and type 2 diabetes (2\,hours post carbohydrate drink).\n- Hematocrit (HCT): Percentage of whole blood volume occupied by erythrocytes (`hemat/o` = blood, `-crit` = to separate).\n- Lipoprotein Panel: Fasting blood test (8\,to\,12\,hours fasting) measuring total cholesterol, HDL, LDL, and triglycerides.\n- Newborn Screening: Performed 24\,to\,48\,hours post-birth via heel prick to detect sickle cell disease, PKU, cystic fibrosis, and metabolic disorders.\n- Prothrombin Time (PT / ProTime): Measures clotting speed. Expressed as an International Normalized Ratio (INR) for patients taking warfarin.\n- Total Protein Test: Measures total serum albumin and globulin, providing an A/G\,ratio.\n- Bone Marrow Aspiration and Biopsy:\n - Aspiration: Withdrawal of liquid bone marrow aspirate using a hollow needle and syringe.\n - Biopsy: Core biopsy needle insertion into bone (typically posterior iliac crest of pelvic bone) to obtain intact bone marrow tissue.\n- Schilling Test: Specialized urine test assessing Vitamin B_{12} absorption to diagnose pernicious anemia.\n\n# Treatment Procedures and Therapies\n\n- Transfusion Therapies:\n - Allogeneic Transfusion: Infusion of compatible blood from a donor (`all/o` = different, `gen` = origin, `-ic` = pertaining to).\n - Autologous Transfusion: Infusion of the patient's own previously donated blood. Cell salvage filters and washes blood lost during surgery to reinfuse it.\n - Platelet Transfusion: Infusion of platelets to treat severe thrombocytopenia and prevent hemorrhage.\n - Apheresis: Automated process withdrawing blood, separating specific desired components (plasma, platelets, WBCs), and returning remaining blood to donor/patient.\n - Platelet-Rich Plasma (PRP) Therapy: Injection of concentrated autologous platelets to promote healing in injured muscles, joints, wounds, hair follicles, or facial skin.\n- Blood Donation Standards:\n - Whole blood can be donated every 56\,days.\n - Concentrated red blood cells can be donated 3\,times\,per\,year.\n - Platelets can be donated every 7\,days((5\,unitsofwholebloodequalof whole blood equal1\,unit of platelets).\n - Type AB+ plasma is universal donor plasma collected for emergency use and therapeutic protein manufacturing.\n- Plasmapheresis and External Treatments:\n - Plasmapheresis: Centrifugal removal of blood plasma (`plasm` = plasma, `-pheresis` = removal); cellular components are resuspended in saline/albumin and reinfused.\n - Therapeutic Plasma Exchange (TPE): Plasmapheresis that removes pathological plasma antibodies and replaces them with donor plasma/substitutes (used in Guillain-BarrΓ© syndrome and multiple sclerosis).\n - Hemodialysis: Dialysis machine filtration of metabolic wastes from blood during renal failure.\n- Hematopoietic Stem Cell Transplantation (HSCT):\n - Procedure replacing dysfunctional bone marrow stem cells to treat leukemias, lymphomas, and multiple myeloma.\n - Conditioning: Chemotherapy and radiation destroy malignant cells, suppress immune rejection, and prepare marrow space.\n - Sources of stem cells: Bone marrow, Peripheral Blood Stem Cells (PBSC), or Umbilical Cord Blood (UCB).\n - Transplant Categories:\n - Autologous (Auto Transplant): Harvests and freezes patient's own PBSCs prior to conditioning.\n - Allogeneic (Allo Transplant): Uses matched donor stem cells.\n - Haploidentical Mismatch Transplant: Uses a 50\%$$ tissue-matched donor (parent, child, sibling).
    • Graft-Versus-Host Disease (GVHD): Serious complication where donor immune cells attack recipient tissues.
  • Medications:
    • Anticoagulants: Slow coagulation and inhibit clot formation. Coumadin (brand name for warfarin) is monitored via PT/INR. Heparin is a fast-acting injectable anticoagulant.
    • Antiplatelet Agents: Low-dose aspirin taken daily reduces platelet aggregation, lowering risk of myocardial infarction or stroke.
    • Topical Hemostatic Agents: Gauze materials applied directly to wounds to promote rapid coagulation.
    • Hematopoietic Growth Factors: Synthetic hormones stimulating bone marrow regeneration of leukocytes or erythrocytes during chemotherapy.

Abbreviations Reference

  • CMP: Comprehensive Metabolic Panel
  • GVHD: Graft-Versus-Host Disease
  • HCT: Hematocrit
  • HGB: Hemoglobin
  • HL: Hodgkin's Lymphoma
  • MM: Multiple Myeloma
  • MDS: Myelodysplastic Syndrome
  • NHL: Non-Hodgkin's Lymphoma
  • PT: Prothrombin Time
  • RBC: Red Blood Cells
  • WBC: White Blood Cells

Critical Thinking Discussion Case Study: "The Human Touch"

  • Narrative Context:
    • Team captain Shanice relies on sophomore athlete Anna to lead the Fighting Knights volleyball team.
    • Teammates Lizbeth and Chen inform Shanice that Anna transitioned to a vegan diet over the summer.
    • Lizbeth notes Anna picked only at a salad and dozed off during a movie. Chen noticed Anna had extreme exertion recovery issues during weight training.
    • Anna dismissed her exhaustion as PMS, but teammates suspect iron deficiency anemia due to a lack of dietary iron sources.
  • Discussion Topics:
    • Topic 1: Is it appropriate for team captain Shanice to inquire about Anna's eating habits? How would considerations shift if dietary restrictions were religious?
    • Topic 2: Given that a well-planned vegan diet can be fully nutritious, what specific steps can an athlete take to maintain adequate dietary iron levels?